Immunohistochemistry analysis further confirmed that EGR2 expression was substantially upregulated in bladder cancer tissues compared to adjacent normal tissues, suggesting a potential role for EGR2 in bladder cancer development or progression. Here, EGR2 is linked to urinary bladder carcinoma.